Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Ipca Laboratories Ltd

Pharmaceuticals & Biotechnology | Mid Cap

Ipca Laboratories Ltd Health Insights
Health Score : 6.33Health Score : 6.33

Ipca Laboratories demonstrates a mixed financial performance. The company shows strong solvency due to a high equity ratio and minimal debt. Growth prospects appear promising, driven by robust revenue, operating profit, and EPS growth rates. However, certain areas need attention, particularly liquidity, which is currently weak. While profitability metrics such as gross profit margin, ROCE, and ROA are good, some financial metrics like adjusted EPS and net margin need improvement. The company's efficiency in utilizing assets is inconsistent, with a strong capital turnover ratio but weak fixed asset and inventory turnover. Overall, Ipca Laboratories exhibits potential for continued growth and profitability, but must address its liquidity and efficiency challenges to realize its full potential.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Ipca Laboratories Ltd Health Insights
Health Score : 6.33Health Score : 6.33

Ipca Laboratories demonstrates a mixed financial performance. The company shows strong solvency due to a high equity ratio and minimal debt. Growth prospects appear promising, driven by robust revenue, operating profit, and EPS growth rates. However, certain areas need attention, particularly liquidity, which is currently weak. While profitability metrics such as gross profit margin, ROCE, and ROA are good, some financial metrics like adjusted EPS and net margin need improvement. The company's efficiency in utilizing assets is inconsistent, with a strong capital turnover ratio but weak fixed asset and inventory turnover. Overall, Ipca Laboratories exhibits potential for continued growth and profitability, but must address its liquidity and efficiency challenges to realize its full potential.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

35.52

Neutral

Industry Median

28.62

Neutral
Neutral

Mid Cap Median

36.34

Neutral

P/E RATIO

35.26

P/B RATIO

4.99

Overvalued

Industry Median

3.17

Overvalued
Undervalued

Mid Cap Median

7.64

Undervalued

P/S RATIO

4.30

Overvalued

Industry Median

3.42

Overvalued
Undervalued

Mid Cap Median

6.30

Undervalued

Others

Overvalued

PEG RATIO

47.64

Overvalued
Overvalued

EV/EBITDA RATIO

19.88

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1585.8 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 8.00

The company exhibits strong growth prospects. The company benefits from robust revenue growth, operating profit growth, and EPS growth rates. This indicates a healthy expansion in its core business and profitability. The company's growth trajectory positions it favorably for future success and value creation. However, the company should ensure that this growth is sustainable and well-managed to maintain its financial health.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate7.457.0223.516.128.42
Operating Profit Growth Rate-14.63-29.6642.0630.7414.33
Earnings Per Share (EPS) Growth-22.45-46.6916.0934.8254.68
Asset Growth Rate25.6513.1328.695.835.33
Net Income Growth Rate-22-46.189.1950.150.83
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 6.00

The company's financial health presents a somewhat mixed picture. While book value per share and capital expenditure are good, adjusted EPS needs improvement. This suggests that the company has a solid foundation, but its ability to generate earnings for its shareholders needs attention. The company should focus on improving its overall financial performance to enhance shareholder value.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
AverageCash Earnings Per Share (Cash EPS)Average
ExcellentBook Value Per ShareExcellent
AverageDividend Per Share (DPS)Average
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)35.8818.821.837.9651.6
Cash Earnings Per Share (Cash EPS)44.8829.6435.247.3264.08
Book Value Per Share218.56233.68253.28277.92322.52
Dividend Per Share (DPS)3.834.094.14.070
Capital Expenditures (CapEx)476458402771317
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 7.20

The company demonstrates strong profitability. Positive profitability metrics include gross profit margin, ROCE, and ROA. However, net profit margin needs improvement. This suggests efficient core operations but potential challenges in managing overall expenses. Enhancing net profit margin while sustaining other profitability metrics can further improve the company's financial performance.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
PoorReturn on Equity (ROE)Poor
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
PoorNet MarginPoor
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin18.8510.812.6214.9816.18
Return on Capital Employed (ROCE)2011131517
Return on Equity (ROE)16.298.28.2611.314.68
Return on Assets (ROA)17.3810.8111.9314.7416
Operating Margin22.8615.0217.2819.4620.52
Net Margin15.357.726.838.8212.27
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.67

The company's efficiency in utilizing its assets is mixed. While capital turnover is good, fixed asset and inventory turnover need improvement. This suggests that the company could optimize its asset management practices to enhance operational efficiency. Efficient asset utilization can lead to cost savings, improved profitability, and enhanced shareholder value. There are definitely areas of Improvement for the Company.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.412.261.682.092.08
Inventory Turnover Ratio2.723.073.183.013.06
Receivables Turnover Ratio6.736.535.7354.96
Days Sales in Inventory Ratio134.19118.89114.78121.26119.28
Receivable Days54.2355.963.77373.59
Capital Turnover Ratio0.990.951.11.181.17
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

The company demonstrates adequate coverage of its financial obligations. The interest coverage ratio is strong, but the equity dividend coverage ratio is weak. This suggests that the company can comfortably meet its interest expenses but may face challenges in covering its dividend payments with equity. The company should manage its coverage ratios prudently to maintain financial stability.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio104.2716.526.9813.8521.7
Equity Dividend Coverage Ratio9.094.555.267.14
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits strong solvency. This indicates a solid financial structure and a low risk of financial distress. The company benefits from a high equity base and minimal reliance on debt financing. This provides stability and flexibility in managing its long-term financial obligations. The company's financial strength allows it to pursue growth opportunities and withstand economic downturns effectively.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.070.10.090.080.03
Debt to Equity Ratio0.080.110.10.090.03
Equity Ratio0.930.90.910.920.97
Debt To Asset Ratio0.050.080.060.050.02
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.00

The company's liquidity position is concerning. This suggests potential difficulties in meeting short-term obligations. Low liquidity can restrict operational flexibility and increase financial risk, particularly in unforeseen circumstances. The company may face challenges in funding immediate expenses and capitalizing on short-term investment opportunities. However, the company should improve its ability to convert assets into cash and better manage its short-term liabilities.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio2.252.421.291.41.5
Quick Ratio1.181.60.690.790.83
Cash Ratio0.370.880.070.080.14
Operating Cash Flow Ratio0.490.380.230.320.28
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 17 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Glaxosmithkline Pharmaceuticals Ltd8.3838.14Neutral1309.0059.731036.00
2J B Chemicals & Pharmaceuticals Ltd8.1449.64Overvalued1107.0041.98709.00
3Gland Pharma Ltd7.9135.27Overvalued1630.0078.881027.00
4Neuland Laboratories Ltd7.8461.14Highly Overvalued574.00283.01364.00
5Ajanta Pharma Ltd7.7236.27Neutral1395.0075.781056.00
6Alembic Pharmaceuticals Ltd7.5422.23Undervalued1118.0032.58671.00
7Syngene International Ltd7.4456.08Overvalued918.007.55317.00
8Emcure Pharmaceuticals Ltd7.4036.42Neutral1865.0038.66941.00
9ERIS Lifesciences Ltd7.1532.39Neutral1120.0017.61648.00
10Laurus Labs Ltd7.1085.84Neutral1778.0013.72890.00
11Glenmark Pharmaceuticals Ltd6.3645.87Neutral4572.00-7.121362.00
12Ipca Laboratories Ltd6.3335.26Neutral1979.0044.641184.00
13Piramal Pharma Ltd5.83-64.86Neutral922.005.27-326.00
14Jubilant Pharmova Ltd5.7138.62Neutral1260.001.25398.00
15Natco Pharma Ltd5.6911.22Neutral1436.0071.551418.00
16Wockhardt Ltd5.07153.40Neutral652.0019.51199.00
17Pfizer Ltd3.4545.16Neutral-82.00157.92300.00
Management Assessment Summary
OrangeBalanced Management

The management of Ipca Laboratories shows a mixed performance. Revenue growth is strong, as seen in the compounded sales growth and recent quarterly improvements. However, profit growth has been inconsistent, with notable fluctuations in quarterly net profits and a recent dip. While the company demonstrates reasonable capital efficiency, its increasing debt levels raise concerns about its long-term financial stability. Promoter holding is stable but has slightly decreased recently. Overall, the inconsistencies in profitability and rising debt warrant caution.

Category Metric Value Assessment
PROS Compounded Sales Growth (TTM) 17% Strong revenue expansion
Promoter Holding (Mar 2025) 44.72% Indicates confidence and alignment
CONS YOY Profit Growth (Mar 2025) 180% Volatile profit growth
Debt/Equity Ratio Increasing Borrowings Leverage is increasing
AverageFinancial Performance & GrowthAverage
AverageCapital Efficiency & ReturnsAverage
WeakFinancial Health & PrudenceWeak
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Ipca Laboratories reveals a moderate level of concern due to segment performance volatility and increasing working capital days. The company's exposure to foreign exchange or interest rate fluctuations, coupled with rising regulatory compliance costs, could further strain profitability. The increasing borrowings also add financial risk. Overall, the company faces notable operational and financial risks that require careful monitoring and strategic mitigation.

AverageSegment performance volatilityAverage
AverageForeign exchange or interest rate exposureAverage
AverageRegulatory compliance cost trendsAverage
01.

Segment performance volatility

02.

Foreign exchange or interest rate exposure

03.

Regulatory compliance cost trends

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101578.89Bullish
  3. SMA 201558.72Bullish
  4. SMA 501576.63Bullish
  5. EMA 101580.20Bullish
  6. EMA 201571.12Bullish
  7. EMA 501575.32Bullish
  8. DEMA 101594.39Bearish
  9. DEMA 201577.47Bullish
  10. DEMA 501564.49Bullish
  11. TEMA 101599.33Bearish
  12. TEMA 201592.87Bearish
  13. TEMA 501559.22Bullish
  14. MACD6.97Bullish
  15. ADX29.44Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI60.28Neutral
  3. CCI89.91Neutral
  4. ROC 93.07Bullish
  5. ROC 142.99Bullish
  6. ROC 251.99Bullish
  7. Stoch K73.41Neutral
  8. Stoch D80.24Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1611.61Neutral
  3. BB Middle1558.73Neutral
  4. BB Lower1505.84Neutral
  5. ATR14.82High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI71.33Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101561.62Bullish
  3. SMA 201560.32Bullish
  4. SMA 501596.89Bearish
  5. EMA 101571.92Bullish
  6. EMA 201571.11Bullish
  7. EMA 501579.60Bullish
  8. DEMA 101581.27Bullish
  9. DEMA 201563.98Bullish
  10. DEMA 501574.21Bullish
  11. TEMA 101594.60Bearish
  12. TEMA 201568.76Bullish
  13. TEMA 501562.76Bullish
  14. MACD-3.11Bullish
  15. ADX18.39Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI56.02Neutral
  3. CCI97.78Neutral
  4. ROC 93.45Bullish
  5. ROC 142.46Bullish
  6. ROC 25-1.52Bearish
  7. Stoch K78.76Neutral
  8. Stoch D77.25Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1605.12Neutral
  3. BB Middle1560.33Neutral
  4. BB Lower1515.53Neutral
  5. ATR20.17Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI51.51Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 101560.79Bullish
  3. SMA 201594.13Bearish
  4. SMA 501592.15Bearish
  5. EMA 101572.17Bullish
  6. EMA 201578.38Bullish
  7. EMA 501578.32Bullish
  8. DEMA 101566.50Bullish
  9. DEMA 201570.64Bullish
  10. DEMA 501590.86Bearish
  11. TEMA 101571.53Bullish
  12. TEMA 201562.11Bullish
  13. TEMA 50N/AN/A
  14. MACD-6.46Bearish
  15. ADX19.81Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI52.45Neutral
  3. CCI-11.36Neutral
  4. ROC 90.86Bullish
  5. ROC 14-2.26Bearish
  6. ROC 253.54Bullish
  7. Stoch K42.84Neutral
  8. Stoch D25.61Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1673.23Neutral
  3. BB Middle1594.13Neutral
  4. BB Lower1515.02Neutral
  5. ATR31.63High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI34.70Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 101596.03Bearish
  3. SMA 201580.60Bearish
  4. SMA 501547.35Bearish
  5. SMA 1001520.78Bullish
  6. SMA 2001452.58Bullish
  7. EMA 101573.01Bearish
  8. EMA 201576.59Bearish
  9. EMA 501558.12Bearish
  10. EMA 1001526.36Bullish
  11. EMA 2001485.97Bullish
  12. DEMA 101560.16Bearish
  13. DEMA 201581.65Bearish
  14. DEMA 501592.08Bearish
  15. DEMA 1001581.27Bearish
  16. DEMA 2001546.56Bearish
  17. TEMA 101545.48Bearish
  18. TEMA 201569.13Bearish
  19. TEMA 501593.11Bearish
  20. TEMA 1001599.42Bearish
  21. TEMA 2001565.90Bearish
  22. MACD1.18Bearish
  23. ADX19.08Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI44.19Neutral
  3. CCI-77.92Neutral
  4. ROC 141.26Bullish
  5. ROC 252.48Bullish
  6. Stoch K37.08Neutral
  7. Stoch D43.11Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1671.35Neutral
  3. BB Middle1580.60Neutral
  4. BB Lower1489.85Neutral
  5. ATR49.10Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI58.17Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 201523.99Bullish
  3. SMA 501454.20Bullish
  4. EMA 201532.60Bullish
  5. EMA 501478.04Bullish
  6. DEMA 201584.55Bearish
  7. DEMA 501544.76Bullish
  8. TEMA 201600.24Bearish
  9. TEMA 501552.62Bullish
  10. MACD39.51Bullish
  11. ADX31.22Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI54.56Neutral
  3. CCI150.89Overbought
  4. ROC 145.94Bullish
  5. ROC 2511.10Bullish
  6. Stoch K63.98Neutral
  7. Stoch D64.92Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1650.79Neutral
  3. BB Middle1523.99Neutral
  4. BB Lower1397.19Neutral
  5. ATR110.77Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI82.20Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 61512.52Bullish
  3. SMA 121448.88Bullish
  4. SMA 241444.17Bullish
  5. EMA 61509.80Bullish
  6. EMA 121473.54Bullish
  7. EMA 241402.31Bullish
  8. DEMA 61546.78Bearish
  9. DEMA 121533.57Bearish
  10. DEMA 241546.14Bearish
  11. TEMA 61553.53Bearish
  12. TEMA 121531.88Bearish
  13. TEMA 241543.61Bearish
  14. MACD182.00Bearish
  15. ADX33.45Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI58.06Neutral
  3. CCI99.83Neutral
  4. ROC 2513.80Bullish
  5. ROC 5043.04Bullish
  6. Stoch K57.10Neutral
  7. Stoch D67.63Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1663.08Neutral
  3. BB Middle1466.98Neutral
  4. BB Lower1270.88Neutral
  5. ATR185.33High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI57.58Neutral